repeated gonadotropin-releasing hormone agonist (GnRH-a) versus low dose human chorionic gonadotropin (HCG)

Phase 3

Recruiting

• Conditions: Infertility associated with polycystic ovarian syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20110731007165N8
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Aged between 18-38 years old
Body mass index below 30 and above 19 kg/m2
Normal uterine cavity
Ovulation induction by GnRH antagonist cycle regimen

Exclusion Criteria

Repeated implantation failure
WHO 1 group
Using Percutaneous Epididymal Sperm Aspiration (PESA) or testicular sperm extraction (TESE)
History of taking oral contraceptive pills for more than three months before the IVF
Endocrinopathies

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ovarian hyperstimulation syndrome (OHSS). Timepoint: At the end of the study. Method of measurement: Hospital records.;Metaphase II (MII) oocytes. Timepoint: At the end of the study. Method of measurement: Hospital records.;Total Number of oocytes. Timepoint: At the end of the study. Method of measurement: Hospital records.;Number of embryos. Timepoint: At the end of the study. Method of measurement: Hospital records.

Secondary Outcome Measures

Name	Time	Method
Endometrial thickness. Timepoint: At the time of embryo transfer. Method of measurement: Vaginal Ultrasound.;Embryos quality. Timepoint: At the end of the study. Method of measurement: Hospital records.